Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W., Wolchok, J. D., Joshua, A. M., . . . Gangadhar, T. C. (2018). Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab. Clin Cancer Res.
Citação norma ChicagoJoseph, Richard W., et al. "Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab." Clin Cancer Res 2018.
Citação norma MLAJoseph, Richard W., et al. "Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab." Clin Cancer Res 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.